Showing 861-870 of 4165 results for "".
A Tale of No Tail: The Impact of Not Purchasing Tail Coverage
https://modernaesthetics.com/ma-issues-index/2015-may-june/a-tale-of-no-tail-the-impact-of-not-purchasing-tail-coverage/34518/Simply terminating your coverage without contemplating the purchase of tail coverage could be a costly mistake.Rethinking Anti-Aging
https://modernaesthetics.com/topics/regenerative-medicine/rethinking-anti-aging/48724/Cellular longevity and the role of mTOR in skin health.Face Value with Modern Aesthetics: Achieving Youthful, Refreshed Look in Mature Patients
https://modernaesthetics.com/series/face-value/face-value-with-modern-aesthetics-achieving-youthful-refreshed-look-in-mature-patients/48762/This week Konstanin Vasyukevich, MD, joins us to address the transformation that reflects what many patients over 60 strive for, a lifted, but natural appearance.Women in Aesthetics: Isabelle Raymond, PhD
https://modernaesthetics.com/ma-issues-index/september-october-2025/women-in-aesthetics-isabelle-raymond-phd/39727/Get to know Isabelle Raymond, PhD, SVP Global Medical and Clinical Affairs with NutrafolFace Value with Modern Aesthetics: 2025 EYECODE Protocol Update Part 3
https://modernaesthetics.com/series/face-value/face-value-with-modern-aesthetics-2025-eyecode-protocol-update-part-3/54626/In the final episode of this 3-part series, Modern Aesthetics medical editor Dr. Saami Khalifian, board member Dr. Sheila Barbarino, and Dr. John Fezza wrap up their discussion on the 2025 EYECODE Protocol Update. This episode breaks down what injectors should do rather than sending their patient toOctane Aesthetics Tech Forum: Guidepoint Qsight Managing Director Reveals New Medical Aesthetics Growth Data
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-guidepoint-qsight-managing-director-reveals-new-medical-aesthetics-growth-data/33865/Modern Aesthetics caught up with Erik Haines, managing director for Guidepoint Qsight at Octane ATF. He details recently released data on the state of the $17.5 billion medical aesthetics industry.ASDS: Dr. Green on the Meeting
https://beta.modernaesthetics.com/conferences/asds-annual-meeting/asds-dr-green-on-the-meeting/33841/Lawrence Green, MD, FAAD, discusses what makes the American Society for Dermatologic Surgery Annual Meeting special.Regeneration Boost
https://beta.modernaesthetics.com/conferences/tell-all-tribune/regeneration-boost/33781/Shino Bay Aguilera, DO, emphasizes the importance of understanding and caring for fibroblasts in aesthetic medicine at the 2024 Tell-All Tribune: An Aesthetic Think Tank. Fibroblasts, the cells responsible for skin health, age over time, leading to decreased function. Dr. Aguilera advocates for a biWomen In Aesthetics: Niquette Hunt
https://modernaesthetics.com/ma-issues-index/2023-sept-oct/women-in-aesthetics-niquette-hunt/35309/The Groundbreaking Original Series from Industry Vet Wendy LewisThe Partnership: Practice Findings & Value Adds
https://beta.modernaesthetics.com/series/revision-skincare/the-partnership-practice-findings-value-adds/33741/This session rounds out the Elite Retreat seminars by sharing top practice analytics connected with value adds to ultimately aid in strategic planning for every practice’s future. AlexSandra Sisler, Sr. Director of Strategic Accounts - Revision Skincare® Scott Kera, Executive Vice President - AEVA D